Filing Details

Accession Number:
0001181431-11-055829
Form Type:
4
Zero Holdings:
No
Publication Time:
2011-11-10 19:03:42
Reporting Period:
2011-11-08
Filing Date:
2011-11-10
Accepted Time:
2011-11-10 19:03:42
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1171298 Solta Medical Inc SLTM Electromedical & Electrotherapeutic Apparatus (3845) 680373593
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1425713 William Brodie C/O Solta Medical, Inc.
25881 Industrial Blvd
Hayward CA 94545
Vice President Of Global Sales No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2011-11-08 5,483 $1.00 86,103 No 4 M Direct
Common Stock Disposition 2011-11-08 5,483 $2.33 80,620 No 4 S Direct
Common Stock Acquisiton 2011-11-09 14,517 $1.00 95,137 No 4 M Direct
Common Stock Disposition 2011-11-09 14,517 $2.25 80,620 No 4 S Direct
Common Stock Acquisiton 2011-11-10 20,000 $1.00 100,620 No 4 M Direct
Common Stock Disposition 2011-11-10 20,000 $2.21 80,620 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Direct
No 4 S Direct
No 4 M Direct
No 4 S Direct
No 4 M Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Employee Stock Option (right to buy) Disposition 2011-11-08 5,483 $0.00 5,483 $1.00
Common Stock Employee Stock Option (right to buy) Disposition 2011-11-09 14,517 $0.00 14,517 $1.00
Common Stock Employee Stock Option (right to buy) Disposition 2011-11-10 20,000 $0.00 20,000 $1.00
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
72,517 2019-02-27 No 4 M Direct
58,000 2019-02-27 No 4 M Direct
38,000 2019-02-27 No 4 M Direct
Footnotes
  1. Represents a weighted average sales price per share. These shares were sold in multiple transactions at prices ranging from $2.33 to $2.35. The reporting person has provided to the issuer, and undertakes to provide the staff of the Securities and Exchange Commission or any security holder of the issuer, upon request, full information regarding the number of shares sold at each separate price within the range.
  2. The options become exercisable as follows:1/48 on March 31, 2009 and 1/48 on the last day of each full calendar month thereafter.